아시아태평양의 비침습적 출생전 검사(NIPT) 시장 규모는 2023년에 6억 5,920만 달러에 달했습니다.
이 시장은 예측 기간인 2023-2033년에 15.43%의 CAGR로 확대하며, 2033년에는 27억 6,730만 달러에 달할 것으로 예측됩니다. 지지적인 헬스케어 정책의 채택, 스크리닝 검사의 보험 적용 범위 확대, 지속적 기술 진보, 지역 전체에서의 기회 확대, 임산부 및 의료 제공자 사이에서 비침습적 검사 방법에 대한 선호도의 증가가 아시아태평양의 비침습적 출생전 검사(NIPT) 시장을 추진하는 주요 요인입니다.
| 주요 시장 통계 | |
|---|---|
| 예측 기간 | 2023-2033년 |
| 2023년 평가 | 6억 5,920만 달러 |
| 2033년 예측 | 27억 6,730만 달러 |
| CAGR | 15.43% |
아시아태평양의 비침습적 출생전 검사(NIPT) 시장은 이 지역에서 헬스케어 지출의 증가와 정교한 출생전 스크리닝 기술에 관한 지식의 증가에 의해 크게 확대하고 있습니다. NIPT는 높은 정확성, 안전성, 비침습성으로 인해 모체 혈액으로부터 세포를 포함하지 않은 태아의 DNA를 조사하는 획기적인 기술로서 더욱 더 인기가 높아지고 있습니다. 임신중 파타우 증후군, 에드워즈 증후군, 다운 증후군과 같은 염색체 이상을 확인하는 데 자주 사용됩니다.
산모의 고령화, 첨단 유전자 기술의 활용, 정확하고 시기적절한 산전 진단의 필요성이 시장 성장을 가속하고 있으며, NIPT의 채택은 많은 아시아태평양 국가에서 산전 진단에 대한 보험 적용 확대와 의료 개혁의 시행으로 인해 더욱 촉진되고 있습니다.
시장의 주요 기업은 이 지역의 다양한 인구와 다양한 소득 수준에 대응하기 위해 합리적인 가격의 검사 솔루션 개발에 주력하고 있습니다. 특히 개발도상국에서 국제 기업과 지역 의료 서비스 프로바이더와의 파트너십을 통해 인지도와 접근성을 높이고 있습니다.
아시아태평양의 비침습적 출생전 검사(NIPT) 시장에 대해 조사했으며, 시장의 개요와 검사법별, 플랫폼별, 최종사용자별, 용도별, 국가별 동향 및 시장에 참여하는 기업의 개요 등을 제공하고 있습니다.
Introduction to Asia-Pacific Non-Invasive Prenatal Testing (NIPT) Market
The Asia-Pacific NIPT market was valued at $659.2 million in 2023 and is expected to reach $2,767.3 million by 2033, registering a CAGR of 15.43% during the forecast period 2023-2033. The adoption of supportive healthcare policies, the growing inclusion of screening procedures in insurance coverage, ongoing technological advancements, the expansion of commercial opportunities throughout the region, and the growing preference for non-invasive testing methods among expectant parents and healthcare providers are the main factors propelling the APAC NIPT market.
Market Introduction
| KEY MARKET STATISTICS | |
|---|---|
| Forecast Period | 2023 - 2033 |
| 2023 Evaluation | $659.2 Million |
| 2033 Forecast | $2,767.3 Million |
| CAGR | 15.43% |
The market for non-invasive prenatal testing (NIPT) in Asia-Pacific is expanding significantly due to increased healthcare spending in the region and growing knowledge of sophisticated prenatal screening techniques. Because of its great accuracy, safety, and non-invasiveness, NIPT-a ground-breaking technology that examines cell-free fetal DNA from maternal blood-is becoming more and more popular. During pregnancy, it is frequently used to identify chromosomal abnormalities such Patau syndrome, Edwards syndrome, and Down syndrome.
Growing maternal age, the use of sophisticated genetic technologies, and the need for accurate and timely prenatal diagnostics are driving the market's growth. The adoption of NIPT is being further supported by the expansion of insurance coverage for prenatal care and the implementation of healthcare reforms in many Asia-Pacific nations.
The market's major players are concentrating on creating affordable testing solutions to serve the region's diverse population and range of income levels. Partnerships between international corporations and regional healthcare providers are increasing awareness and accessibility, especially in developing nations.
As prenatal health awareness rises and healthcare infrastructure improves, the APAC NIPT market is expected to grow rapidly. It will be crucial in improving maternal and fetal health outcomes throughout the area.
Market Segmentation:
Segmentation 1: by Application
Segmentation 2: by End User
Segmentation 3: by Platform
Segmentation 4: by Method
Segmentation 5: by Country
How can this report add value to an organization?
Workflow/Innovation Strategy: The Asia-Pacific NIPT market (by application) has been segmented into detailed segments of the application of NIPT based on applications, including trisomy detection, microdeletion detection, sex chromosome aneuploidy detection, and others.
Growth/Marketing Strategy: Constant advancement and innovation to enhance performance and efficiency can enabled prominent players to command premium prices while maintaining growth in revenue and volume.
Competitive Strategy: Key players in the Asia-Pacific NIPT market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the Asia-Pacific NIPT market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on thorough secondary research, which includes analyzing company coverage, product portfolio, market penetration, and insights gathered from primary experts.
Some prominent names established in this market are:
Scope and Definition